http://www.eyenoviabio.com
Eyenovia, Inc. Company Intro
Making it Possible Envision a world where progressive myopia is a thing of the past. With our transformative microdosing technology, we are developing a treatment for progressive myopia, a condition which is associated with several back of the eye diseases and may result in visual disability. Making it Possible Envision a world where progressive myopia […]
Industry
Healthcare
Eyenovia, Inc. Headquaters
295 Madison Avenue
New York,10017
United States
Eyenovia, Inc. Share price
17 May 2023 13:10 GMT
$3.2800
-0.02 (-0.46 %)
Eyenovia, Inc. Market cap
$128.83 M
WMC RANKING
2024
Eyenovia, Inc. # 232
BiotechnologyLatest Eyenovia, Inc. News
10 Feb 2024
Glaucoma 360: 'Innovation is marching on'
Adrienne Graves, PhD, and Andrew Iwach, MD, co-founders of Glaucoma 360, highlight the 13th annual Glaucoma 360 New Horizons Forum, held this year at the...
10 Feb 2024
Glaucoma 360: Innovations in glaucoma drugs and drug delivery
Joseph Panarelli, MD, sat down with David Hutton of Ophthalmology Times to discuss the panel he moderated at the Glaucoma 360 meeting held in San Francisco,...
10 Feb 2024
Glaucoma 360: 'Innovation is marching on'
Adrienne Graves, PhD, and Andrew Iwach, MD, co-founders of Glaucoma 360, highlight the 13th annual Glaucoma 360 New Horizons Forum, held this year at the...
WMC Market Score
WMC Market to Revenue Score
Eyenovia, Inc. Market Financials
Revenue, Expenses, Profit
| Company | Currency | Revenue | Expense | Profit | Market Cap | WMC Sector Score |
| Eyenovia, Inc. | USD | $4,000 | $22,056 | $-19,671 | $1,288M | 232 |
| Regeneron Pharmaceuticals, Inc. | USD | $9,197,600 | $3,997,800 | $4,003,800 | $804,390B | 1 |
| Vertex Pharmaceuticals Incorporated | USD | $6,414,881 | $2,617,257 | $2,762,032 | $878,880B | 2 |
| Alexion Pharmaceuticals, Inc. | USD | $6,261,601 | $2,747,200 | $681,800 | $ 0.00 | 3 |
| ALK-Abello A/S | USD | $3,556,000 | $1,893,000 | $66,000 | $189,400B | 4 |
Market Analytics
Company Search vs Top 4 Industry Competitors
Total Eyenovia, Inc. Social Followers vs Top 4 Industry Competitors
Eyenovia, Inc. Post vs Top 4 Industry Competitors
Eyenovia, Inc. Digital Footprint By Size vs Top 4 Industry Competitors
Eyenovia, Inc. Digital Footprint By Change Rate vs Top 4 Industry Competitors
Eyenovia, Inc. WMC Market Score Calculations
| Details | Revenue | Total Social Followers | Total Social Posts | Search Volume | Digital Footprint Size | Digital change (New Pages) | WMC Market Score |
| Eyenovia, Inc. | 0.04 | 0.74 | 0.01 | 0 | 0 | 0 | 0.27 |
| Regeneron Pharmaceuticals, Inc. | 100 | 25.50 | 16.15 | 70 | 0 | 0 | 39.85 |
| Vertex Pharmaceuticals Incorporated | 69.75 | 35.68 | 8.95 | 100 | 0 | 0 | 51.56 |
| Alexion Pharmaceuticals, Inc. | 68.08 | 100 | 100 | 80 | 0 | 0 | 100 |
| ALK-Abello A/S | 38.66 | 0 | 0 | 0 | 0 | 0 | 0 |
Book a demo
Book a free one-on-one demo with one of our team and see exactly how the WMC business intelligence platform can help you protect and grow revenue.
* required fields
You'll learn how to:
- 1. Automatically monitor your entire digital landscape including competitors
- 2. View all new industry activity in real time
- 3. Monitor your position in your industry
- 4. Enrich your reports and strategy
- 5. Empower your teams with knowledge
